Literature DB >> 9258180

What imaging studies are necessary to determine outcome after ureteroneocystostomy?

M D Bomalaski1, M L Ritchey, D A Bloom.   

Abstract

PURPOSE: After ureteroneocystostomy we have performed renal ultrasonography within the first 3 months to exclude hydronephrosis, voiding cystography after 3 months to exclude vesicoureteral reflux and subsequent ultrasonography to monitor the upper tracts. This study attempted to determine those patients at risk for hydronephrosis or recurrent vesicoureteral reflux.
MATERIALS AND METHODS: We studied the records of patients who underwent ureteroneocystostomy in the last decade at our institutions to find the incidence and degree of preoperative and postoperative hydronephrosis and vesicoureteral reflux. Results of initial postoperative imaging were compared to radiological imaging throughout followup (mean 2.3 years). Patients with postoperative reflux were evaluated for risk factors that differentiated them from others.
RESULTS: Excluding patients with neuropathic bladder or ureterocele, 167 underwent 278 ureteroneocystostomies at a mean followup of 26.5 months. Persistent vesicoureteral reflux was noted in 4 kidneys (1.4%) and contralateral reflux developed in 3 of the 48 cases (6.3%) of unilateral ureteroneocystostomy. There was no statistical difference in success rates among cross-trigonal, ureteral advancement or extravesical techniques. New onset mild hydronephrosis in 13 kidneys (4.7%) at the initial followup study (mean 1.6 months) completely resolved in 12 and remained mild in 1. No patient had progression of existing hydronephrosis and 1 had recurrent vesicoureteral reflux after initial negative cystography. Risk factors for postoperative reflux or hydronephrosis were preoperative dysfunctional voiding, preoperative hydronephrosis or scarring on sonography and postoperative urinary tract infection. None of the 88 patients without these risk factors had postoperative hydronephrosis or reflux. All patients with persistent, contralateral or recurrent reflux were selected using these criteria (p < 0.003).
CONCLUSIONS: Complication rates after nontapered ureteroneocystostomy in children without neuropathic bladder are quite low. Mild postoperative hydronephrosis was not clinically significant in our patients. Children with abnormal preoperative ultrasound or dysfunctional voiding are identified as a high risk group for postoperative hydronephrosis or recurrent reflux. All other patients received little benefit from postoperative imaging, suggesting that further evaluation of this group is necessary only in the presence of a postoperative urinary tract infection.

Entities:  

Mesh:

Year:  1997        PMID: 9258180     DOI: 10.1097/00005392-199709000-00144

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  10 in total

1.  Durability of antireflux effect of ureteral reimplantation for primary vesicoureteral reflux: findings on long-term cystography.

Authors:  Katherine C Hubert; Paul J Kokorowski; Lin Huang; Michaella M Prasad; Ilina Rosoklija; Alan B Retik; Caleb P Nelson
Journal:  Urology       Date:  2012-01-13       Impact factor: 2.649

2.  Clinical outcomes and long-term resolution in patients with persistent vesicoureteral reflux after open ureteral reimplantation.

Authors:  Katherine C Hubert; Paul J Kokorowski; Lin Huang; Michaella M Prasad; Ilina Rosoklija; Alan B Retik; Caleb P Nelson
Journal:  J Urol       Date:  2012-08-17       Impact factor: 7.450

3.  Bilateral ureteral tapering and secondary ureteroneocystostomy for late stenosis in a patient with bladder extrophy.

Authors:  Emanuela Altobelli; Alfredo M Bove; Federico Sergi; Maurizio Buscarini
Journal:  Curr Urol       Date:  2013-02-08

4.  Significance of an endoscopically injected nodule detected on ultrasound as a predictive factor for the resolution of vesicoureteral reflux.

Authors:  Dong-Gi Lee; Sin Woo Lee; Kwan Hyun Park; Dong Soo Ryu; Minki Baek
Journal:  Exp Ther Med       Date:  2015-01-22       Impact factor: 2.447

Review 5.  Urinary tract infection in the setting of vesicoureteral reflux.

Authors:  Michael L Garcia-Roig; Andrew J Kirsch
Journal:  F1000Res       Date:  2016-06-30

6.  Subureteral Injection with Small-Size Dextranomer/Hyaluronic Acid Copolymer: Is It Really Efficient?

Authors:  Iyimser Üre; Serhat Gürocak; Özgür Tan; Amirali Farahvash; Cem Senol; Hüseyin Gümüstas; Irfan Atay; Nuri Deniz
Journal:  Biomed Res Int       Date:  2016-12-26       Impact factor: 3.411

7.  Unilateral extravesical ureteral reimplantation via inguinal incision for the correction of vesicoureteral reflux: a 10-year experience.

Authors:  Michael Yap; Unwanabong Nseyo; Hena Din; Madhu Alagiri
Journal:  Int Braz J Urol       Date:  2017 Sep-Oct       Impact factor: 1.541

8.  Severe hydronephrosis and dysuria-hematuria syndrome after 20 years of bladder exstrophy correction: a case report.

Authors:  Emanuela Altobelli; Alfredo Maria Bove; Federico Sergi; Marzio Angelo Zullo; Maurizio Buscarini
Journal:  Case Rep Urol       Date:  2012-11-11

Review 9.  Management of vesicoureteral reflux in children.

Authors:  S P Greenfield
Journal:  Curr Urol Rep       Date:  2001-04       Impact factor: 2.862

10.  Guidelines for the medical management of pediatric vesicoureteral reflux.

Authors:  Hideshi Miyakita; Yutaro Hayashi; Takahiko Mitsui; Manabu Okawada; Yoshiaki Kinoshita; Takahisa Kimata; Yasuhiro Koikawa; Kiyohide Sakai; Hiroyuki Satoh; Masatoshi Tokunaga; Yasuyuki Naitoh; Fumio Niimura; Hirofumi Matsuoka; Kentaro Mizuno; Kazunari Kaneko; Masayuki Kubota
Journal:  Int J Urol       Date:  2020-04-01       Impact factor: 3.369

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.